Stephen Zeimantz, NP

NPI: 1922001478
Total Payments
$939.21
2023 Payments
$258.61
Companies
8
Transactions
39
Medicare Patients
319
Medicare Billing
$18,447

Payment Breakdown by Category

Food & Beverage$939.21 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $939.21 39 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $388.30 23 $0 (2023)
Janssen Pharmaceuticals, Inc $248.68 4 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $123.58 6 $0 (2023)
Actelion Pharmaceuticals US, Inc. $67.93 1 $0 (2022)
Hologic, LLC $48.49 1 $0 (2022)
Alkermes, Inc. $31.25 2 $0 (2022)
ITI, Inc. $18.74 1 $0 (2022)
Corium, LLC $12.24 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $258.61 13 ABBVIE INC. ($131.28)
2022 $378.03 12 Janssen Pharmaceuticals, Inc ($138.01)
2021 $302.57 14 AbbVie Inc. ($232.08)

All Payment Transactions

39 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/16/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $32.54 General
Category: NEUROSCIENCE
06/01/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.93 General
Category: NEUROSCIENCE
05/31/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.58 General
Category: NEUROSCIENCE
05/04/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.14 General
Category: NEUROSCIENCE
04/20/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.84 General
Category: NEUROSCIENCE
04/11/2023 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $55.13 General
Category: Neuroscience
04/06/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.04 General
Category: NEUROSCIENCE
03/08/2023 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $55.54 General
Category: Neuroscience
03/08/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $19.56 General
Category: NEUROSCIENCE
03/02/2023 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $16.66 General
Category: NEUROSCIENCE
02/16/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.01 General
Category: NEUROSCIENCE
01/12/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.77 General
Category: NEUROSCIENCE
01/05/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.87 General
Category: NEUROSCIENCE
12/08/2022 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $15.51 General
Category: Neuroscience
10/07/2022 Hologic, LLC THINPREP 2000 PROCESSOR (Device), APTIMA Food and Beverage In-kind items and services $48.49 General
Category: Diagnostics
09/22/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $18.25 General
Category: NEUROSCIENCE
09/01/2022 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $67.93 General
Category: Cardiology
09/01/2022 Corium, LLC AZSTARYS (Drug) Food and Beverage In-kind items and services $12.24 General
Category: CNS Stimulant for ADHD
08/25/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $18.74 General
Category: PSYCHIATRY
06/30/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $19.35 General
Category: CNS
06/16/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $122.50 General
Category: Neuroscience
05/19/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.75 General
Category: NEUROSCIENCE
05/05/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $13.19 General
Category: NEUROSCIENCE
03/31/2022 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $18.18 General
Category: NEUROSCIENCE
01/27/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $11.90 General
Category: CNS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 72 79 $16,616 $3,378
2022 2 71 98 $15,581 $3,802
2021 4 108 163 $25,034 $7,869
2020 2 68 105 $13,798 $3,399
Total Patients
319
Total Services
445
Medicare Billing
$18,447
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 31 33 $5,819 $1,340 23.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 29 34 $7,545 $1,330 17.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $3,252 $708.00 21.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 38 58 $10,484 $2,631 25.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 33 40 $5,097 $1,171 23.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 47 81 $13,150 $4,246 32.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 38 58 $5,968 $1,955 32.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 12 13 $3,166 $971.02 30.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 11 11 $2,750 $696.48 25.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 31 61 $9,492 $2,382 25.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 37 44 $4,306 $1,017 23.6%

About Stephen Zeimantz, NP

Stephen Zeimantz, NP is a Nurse Practitioner healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922001478.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephen Zeimantz, NP has received a total of $939.21 in payments from pharmaceutical and medical device companies, with $258.61 received in 2023. These payments were reported across 39 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($939.21).

As a Medicare-enrolled provider, Zeimantz has provided services to 319 Medicare beneficiaries, totaling 445 services with total Medicare billing of $18,447. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Nurse Practitioner
  • Location Portland, OR
  • Active Since 05/28/2005
  • Last Updated 03/14/2025
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1922001478

Products in Payments

  • VRAYLAR (Drug) $355.55
  • SPRAVATO (Drug) $126.18
  • INVEGA SUSTENNA (Drug) $122.50
  • TRINTELLIX (Drug) $105.40
  • UPTRAVI (Drug) $67.93
  • THINPREP 2000 PROCESSOR (Device) $48.49
  • ARISTADA (Drug) $31.25
  • UBRELVY (Drug) $19.56
  • CAPLYTA (Drug) $18.74
  • VYVANSE (Drug) $18.18
  • QULIPTA (Drug) $13.19
  • AZSTARYS (Drug) $12.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Portland